lamivudine has been researched along with Diabetic Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassetti, D; Bassetti, M; Briozzo, A; Cruciani, M; Di Biagio, A; Ferrazin, A; Gatti, G; Rosso, R | 1 |
| Al Faraidy, K; Anderson, FH; Davis, JE; Steinbrecher, UP; Vartanian, RK; Yoshida, EM | 1 |
2 other study(ies) available for lamivudine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Tenofovir use in a patient with a severe renal impairment.
Topics: Adenine; Adult; Diabetic Nephropathies; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome | 2004 |
Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine.
Topics: Antiviral Agents; Cholestasis, Intrahepatic; Diabetic Nephropathies; DNA, Viral; Graft Survival; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Liver; Liver Function Tests; Living Donors; Male; Middle Aged; Recurrence; Transplantation, Homologous; Virus Replication | 1997 |